BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 89175)

  • 1. [Therapeutic effects of anti-OEP-antibodies in the Pseudomonas aeruginosa (Fisher's seven serotypes) infection of mice and the influence of this antibody upon the phagocytic activity of mice spleen macrophages (author's transl)].
    Haranaka K; Satomi N; Matsuo M; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Apr; 53(4):175-81. PubMed ID: 89175
    [No Abstract]   [Full Text] [Related]  

  • 2. [The differentiation of OEP-HA titer between gamma-globulin products for intravenous use and their effectiveness in the passive protection of mice against Pseudomonas aeruginosa infection (author's transl)].
    Haranaka K; Satomi N; Matsuo M; Fukaya K; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1978 Nov; 52(11):490-6. PubMed ID: 85678
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of anti-OEP-IgG and -IgM upon mouse spleen macrophage. Phagocytic activity against Pseudomonas aeruginosa and OEP-coated latex granules (author's transl)].
    Haranaka K; Matsuo M; Satomi N; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1978 Nov; 52(11):482-9. PubMed ID: 107248
    [No Abstract]   [Full Text] [Related]  

  • 4. [The changes of the OEP-HA titer in the sera of mice challenged with Pseudomonas aeruginosa and in the phagocytic system of macrophages in vitro (author's transl)].
    Satomi N; Haranaka K; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Aug; 53(8):350-8. PubMed ID: 119815
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
    Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
    Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhancement of phagocytosis and intra-cellular killing of Pseudomonas aeruginosa and its common antigen (OEP) coated latex particles by mouse spleen macrophages to which anti-OEP-IgG and gentamicin have been added.
    Haranaka K; Matsuo M; Mashimo K
    Jpn J Exp Med; 1977 Feb; 47(1):35-40. PubMed ID: 404451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
    Fisher MW
    J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common protective antigen (OEP) of Pseudomonas aeruginosa.
    Abe C; Shionoya H; Hirao Y; Okada K; Homma JY
    Jpn J Exp Med; 1975 Oct; 45(5):355-9. PubMed ID: 817054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The necessity of i.v. human immunoglobulin therapy for Pseudomonas aeruginosa infection].
    Nishimura T
    Nihon Rinsho; 1991 Oct; 49(10):2431-40. PubMed ID: 1721099
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
    Kamimura T
    Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the (Fab')2 fragment of the anti-Pseudomonas aeruginosa antibodies on Pseudomonas-induced keratitis in rats].
    Ren PX
    Yan Ke Xue Bao; 1986 Dec; 2(4):255-7. PubMed ID: 3147914
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of OEP-antibodies in Pseudomonas aeruginosa infection.
    Doi T; Nakajima T
    Jpn J Exp Med; 1978 Aug; 48(4):287-95. PubMed ID: 101701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
    Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
    Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies to Pseudomonas aeruginosa produced by EBV-transformed cells.
    Suzuki H; Okubo Y; Moriyama M; Sasaki M; Matsumoto Y; Hozumi T
    Microbiol Immunol; 1987; 31(10):959-66. PubMed ID: 2828894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the Pseudomonas aeruginosa infections--frequency, antibiotics sensitivity, OEP-HA titer (author's transl)].
    Satomi N; Haranaka K; Fukaya K; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Apr; 53(4):167-74. PubMed ID: 112204
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemagglutination titer of gamma-globulin preparations for intravenous use against OEP (original endotoxin protein), protease and elastase of Pseudomonas aeruginosa (author's transl)].
    Yamashita N; Jozaki K; Iwata S; Iwasaki Y; Sunakawa K
    Kansenshogaku Zasshi; 1981 Sep; 55(9):637-41. PubMed ID: 6172525
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J; Fisher A; Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.